These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 7898240
21. Randomized, placebo-controlled trial of gastric acid-lowering therapy on duodenal polyposis and relative adduct labeling in familial adenomatous polyposis. Wallace MH, Forbes A, Beveridge IG, Spigelman AD, Hewer A, Venitt S, Phillips RK. Dis Colon Rectum; 2001 Nov; 44(11):1585-9. PubMed ID: 11711728 [Abstract] [Full Text] [Related]
22. Effect of sulindac treatment for attenuated familial adenomatous polyposis with a new germline APC mutation at codon 161: report of a case. Esaki M, Matsumoto T, Mizuno M, Kobori Y, Yoshimura R, Yao T, Iida M. Dis Colon Rectum; 2002 Oct; 45(10):1397-402; discussion 1402-6. PubMed ID: 12394442 [Abstract] [Full Text] [Related]
23. Gastroduodenal polyps in familial adenomatous and juvenile polyposis. Järvinen HJ, Sipponen P. Endoscopy; 1986 Nov; 18(6):230-4. PubMed ID: 3024956 [Abstract] [Full Text] [Related]
24. [Rectal micropolyps after total colectomy in familial polyposis. Efficacy of sulindac]. Charneau J, D'Aubigny N, Burtin P, Person B, Boyer J. Gastroenterol Clin Biol; 1990 Nov; 14(2):153-7. PubMed ID: 2158470 [Abstract] [Full Text] [Related]
25. [Sulindac in familial adenomatous polyposis coli--preliminary findings of a prospective study]. Müller A, Hürlimann R, Meyenberger C, Staub P, Kobler E, Ammann R. Schweiz Med Wochenschr; 1994 Apr 16; 124(15):651-4. PubMed ID: 8191270 [Abstract] [Full Text] [Related]
26. Is epidermal growth factor involved in development of duodenal polyps in familial polyposis coli? Bülow S, Skov Olsen P, Poulsen SS, Kirkegaard P. Am J Gastroenterol; 1988 Apr 16; 83(4):404-6. PubMed ID: 2831708 [Abstract] [Full Text] [Related]
27. Sulindac in familial adenomatous polyposis: evaluation by nuclear morphometry. Fernández-López F, Conde-Freire R, Cadarso-Suárez C, García-Iglesias J, Puente-Domínguez JL, Potel-Lesquereux J. Eur J Surg; 2001 May 16; 167(5):375-81. PubMed ID: 11419555 [Abstract] [Full Text] [Related]
28. Sulindac and Erlotinib for Familial Adenomatous Polyposis. Matuchansky C. JAMA; 2016 Aug 02; 316(5):544-5. PubMed ID: 27483077 [No Abstract] [Full Text] [Related]
29. Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis. Keller JJ, Offerhaus GJ, Drillenburg P, Caspers E, Musler A, Ristimäki A, Giardiello FM. Clin Cancer Res; 2001 Dec 02; 7(12):4000-7. PubMed ID: 11751493 [Abstract] [Full Text] [Related]
30. Sulindac and Erlotinib for Familial Adenomatous Polyposis--Reply. Samadder NJ, Neklason DW, Burt RW. JAMA; 2016 Aug 02; 316(5):545. PubMed ID: 27483082 [No Abstract] [Full Text] [Related]
31. Frequency of small bowel polyps in patients with duodenal adenoma but without familial adenomatous polyposis. Riemann JF, Hartmann D, Schilling D, Damian U, Eickhoff A, Weickert U. Z Gastroenterol; 2006 Mar 02; 44(3):235-8. PubMed ID: 16514568 [Abstract] [Full Text] [Related]
32. FAP with concurrent duodenal adenomatous polyposis and carcinoid tumor. Camp ER, Hochwald SN, Liu C. J Surg Oncol; 2004 Sep 15; 87(4):187-90. PubMed ID: 15334634 [Abstract] [Full Text] [Related]